Correction: Cytomembrane-mimicking nanocarriers with a scaffold consisting of a CD44-targeted endogenous component for effective asparaginase supramolecule delivery.

Autor: Huang Y; Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, Chongqing 400016, China. zjqrae01@163.com., Gu J; Department of Thoracic Surgery, Daping Hospital of Army Medical University, PLA, Chongqing 400042, China. tanqy001@163.com., Yan Z; Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, Chongqing 400016, China. zjqrae01@163.com., Hu X; Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, Chongqing 400016, China. zjqrae01@163.com., He D; Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, Chongqing 400016, China. zjqrae01@163.com., Zhang Y; Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, Chongqing 400016, China. zjqrae01@163.com., Li Y; Division of infectious disease, Chongqing Public Health Medical Center, Chongqing 400036, China., Zhong C; Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, Chongqing 400016, China. zjqrae01@163.com., Yang J; Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, Chongqing 400016, China. zjqrae01@163.com., Shi D; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093, USA., Abagyan R; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093, USA., Tan Q; Department of Thoracic Surgery, Daping Hospital of Army Medical University, PLA, Chongqing 400042, China. tanqy001@163.com., Zhang J; Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, Chongqing 400016, China. zjqrae01@163.com.

Publikováno v: Nanoscale [Nanoscale] 2024 Nov 22. Date of Electronic Publication: 2024 Nov 22.

Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System.

Autor: Makunts T; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, United States., Abagyan R; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, United States.

Publikováno v: Frontiers in psychiatry [Front Psychiatry] 2024 Jun 18; Vol. 15, pp. 1414622. Date of Electronic Publication: 2024 Jun 18 (Print Publication: 2024).

De novo generation of multi-target compounds using deep generative chemistry.

Autor: Munson BP; Division of Human Genomics and Precision Medicine, Department of Medicine, University of California San Diego, La Jolla, CA, 92093, USA.; Department of Bioengineering, University of California San Diego, La Jolla, CA, 92093, USA., Chen M; Division of Human Genomics and Precision Medicine, Department of Medicine, University of California San Diego, La Jolla, CA, 92093, USA., Bogosian A; Division of Human Genomics and Precision Medicine, Department of Medicine, University of California San Diego, La Jolla, CA, 92093, USA., Kreisberg JF; Division of Human Genomics and Precision Medicine, Department of Medicine, University of California San Diego, La Jolla, CA, 92093, USA., Licon K; Division of Human Genomics and Precision Medicine, Department of Medicine, University of California San Diego, La Jolla, CA, 92093, USA., Abagyan R; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, 92093, USA., Kuenzi BM; Division of Human Genomics and Precision Medicine, Department of Medicine, University of California San Diego, La Jolla, CA, 92093, USA., Ideker T; Division of Human Genomics and Precision Medicine, Department of Medicine, University of California San Diego, La Jolla, CA, 92093, USA. tideker@health.ucsd.edu.; Department of Bioengineering, University of California San Diego, La Jolla, CA, 92093, USA. tideker@health.ucsd.edu.; Department of Computer Science and Engineering, University of California San Diego, La Jolla, CA, 92093, USA. tideker@health.ucsd.edu.

Publikováno v: Nature communications [Nat Commun] 2024 May 06; Vol. 15 (1), pp. 3636. Date of Electronic Publication: 2024 May 06.

Authors' Response to Peer Reviews of "Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis".

Autor: Makunts T; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, United States., Joulfayan H; University of California San Diego, La Jolla, CA, United States., Abagyan R; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, United States.

Publikováno v: JMIRx med [JMIRx Med] 2024 May 01; Vol. 5, pp. e58273. Date of Electronic Publication: 2024 May 01.

Thyroid hyperplasia and neoplasm adverse events associated with GLP-1 receptor agonists in FDA Adverse Event Reporting System.

Autor: Makunts T, Joulfayan H, Abagyan R

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2023 Nov 24. Date of Electronic Publication: 2023 Nov 24.